Hester Biosciences Limited (BOM:524669)
India flag India · Delayed Price · Currency is INR
2,107.00
-6.80 (-0.32%)
At close: Sep 10, 2025

Hester Biosciences Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 20212017 - 2021
Period Ending
Jun '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2017 - 2021
Operating Revenue
3,1293,1113,0452,6612,3502,143
Upgrade
Other Revenue
24.6313.7266.48121.14116.4133.64
Upgrade
3,1543,1253,1122,7822,4662,177
Upgrade
Revenue Growth (YoY)
3.18%0.41%11.86%12.80%13.30%15.94%
Upgrade
Cost of Revenue
918.6928.37997.28824.81678.19527.1
Upgrade
Gross Profit
2,2352,1962,1151,9571,7881,650
Upgrade
Selling, General & Admin
721.34728.49752.69675.39516.02440.33
Upgrade
Other Operating Expenses
827.3843.64758.94654.62536.16478.27
Upgrade
Operating Expenses
1,7171,7401,6831,5371,2381,059
Upgrade
Operating Income
518.29456.22431.29420.28550.43591.22
Upgrade
Interest Expense
-51.41-83.4-91.19-51.49-25.76-60.62
Upgrade
Interest & Investment Income
20.3720.3719.0721.7319.0312.94
Upgrade
Earnings From Equity Investments
42.894146.0944.094.23-
Upgrade
Currency Exchange Gain (Loss)
-33.62-33.62-94.68-29.92-4.59-4.03
Upgrade
Other Non Operating Income (Expenses)
-4.86-4.86-3.1-3.31-9.57-5.42
Upgrade
EBT Excluding Unusual Items
491.66395.71307.48401.38533.77534.09
Upgrade
Gain (Loss) on Sale of Assets
--0.280.161.250.15
Upgrade
Other Unusual Items
--11.77---33.21
Upgrade
Pretax Income
491.66395.71319.53401.54535.02501.03
Upgrade
Income Tax Expense
105.3107.45107.87121.19140.18154.05
Upgrade
Earnings From Continuing Operations
386.36288.26211.66280.35394.84346.98
Upgrade
Minority Interest in Earnings
-10.42-13.38-22.77-14.08-1.64-2.68
Upgrade
Net Income
375.94274.88188.89266.27393.2344.3
Upgrade
Net Income to Common
375.94274.88188.89266.27393.2344.3
Upgrade
Net Income Growth
94.22%45.52%-29.06%-32.28%14.20%18.03%
Upgrade
Shares Outstanding (Basic)
999999
Upgrade
Shares Outstanding (Diluted)
999999
Upgrade
Shares Change (YoY)
3.33%-----
Upgrade
EPS (Basic)
43.0732.3122.2031.3046.2240.47
Upgrade
EPS (Diluted)
43.0732.3122.2031.3046.2240.47
Upgrade
EPS Growth
87.96%45.52%-29.06%-32.28%14.20%18.03%
Upgrade
Free Cash Flow
-439.2237.86-541.66-869.98173.11
Upgrade
Free Cash Flow Per Share
-51.6327.96-63.67-102.2720.35
Upgrade
Dividend Per Share
-7.0006.0008.00010.00010.000
Upgrade
Dividend Growth
-16.67%-25.00%-20.00%-51.52%
Upgrade
Gross Margin
70.88%70.29%67.95%70.35%72.50%75.79%
Upgrade
Operating Margin
16.43%14.60%13.86%15.11%22.32%27.16%
Upgrade
Profit Margin
11.92%8.80%6.07%9.57%15.94%15.82%
Upgrade
Free Cash Flow Margin
-14.06%7.64%-19.47%-35.27%7.95%
Upgrade
EBITDA
681.33620.39599.98624.22712.92720.33
Upgrade
EBITDA Margin
21.60%19.85%19.28%22.44%28.90%33.09%
Upgrade
D&A For EBITDA
163.04164.17168.69203.94162.49129.11
Upgrade
EBIT
518.29456.22431.29420.28550.43591.22
Upgrade
EBIT Margin
16.43%14.60%13.86%15.11%22.32%27.16%
Upgrade
Effective Tax Rate
21.42%27.15%33.76%30.18%26.20%30.75%
Upgrade
Revenue as Reported
3,1803,1503,1522,8122,4872,190
Upgrade
Advertising Expenses
-77.7388.0699.7449.6337.96
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.